Knockdown of LGR4 resulted in the inhibition of stem cell transcription factors (POU5F1 and SOX2), reduction of cell surface markers (CD133, ALDH1A2), and suppression of tumor growth and metastasis of ovarian cancer cell lines. This evidence concerns the gene LGR4 and ovarian carcinoma.